Global Life Science Tools and Services Market: Key Growth Drivers and Trends with 10-11% CAGR by 2029

The global life science tools and services market is set to witness a growth rate of 10-11% in the next 5 years. Rising demand for biologics and biosimilars, technological advancements in life science tools, increased government funding for life science technologies, increased adoption of advanced technologies such as sequencing and chromatography, and growing focus on food testing and environmental health are some of the key factors driving the market growth. 

Life science’ is an umbrella term that studies organisms and microorganisms. Different fields fall under life science such as cell biology, biotechnology, genetics, molecular biology, biomedicine, and biochemistry. The life science tools and services market is segmented based on technique, products & services and end user.

🔗 Want deeper insights? Download the sample report here:
https://meditechinsights.com/life-science-tools-and-services-market/request-sample/

Technological Advancements in Life Science Tools and Services Market to Fuel Its Global Demand

Continuous advancements in the life science tools and services market have enabled the development of efficient products with advanced capabilities, increased applications, and cost-effectiveness. Such advancements tend to provide a competitive edge to manufacturers. Therefore, major players are continuously investing in research activities for new product development and expanding their geographic reach to strengthen their position in the life science tools and services market. Some of the technological advancements are listed below:

• In May 2024, Agilent Technologies Inc. introduced the 8850 Gas Chromatograph, a compact, energy-efficient system that merges the legacy of the 6850 GC with the intelligence and capabilities of the 8890 GC, designed to enhance laboratory efficiency across industries like energy, chemicals, food, and pharmaceuticals
• In December 2023, Merck introduced AIDDISON the first AI-driven drug discovery software that integrates virtual molecule design with real-world manufacturability by combining generative AI, machine learning, and Synthia retrosynthesis API to enhance drug discovery and synthesis processes.
• In August 2022, Roche launched its Digital Light Cycler System, a next-generation digital PCR system to assist clinical researchers in better understanding the nature of a patient’s infection, genetic disease or cancer, leading to early diagnosis
• In June 2022, Waters Corporation introduced the New Xevo G3 quadrupole time-of-flight mass spectrometer, a more sensitive spectrometer than its predecessor to drive drug discovery and development
• In May 2022, Bio-Rad Laboratories, Inc. launched the CFX Duet Real-Time PCR System to help researchers develop singleplex and duplex quantitative PCR (qPCR) assays by offering a robust thermal performance featuring its proprietary and accurate optical shuttle system
• In March 2022, Element Biosciences Inc. launched its benchtop sequencer - Element AVITI System, which offers a combination of performance, cost, and flexibility in an unprecedented way. This system consists of a benchtop NGS instrument and related consumables
• In August 2021, Becton, Dickinson and Company launched its benchtop cell analyzer “FACSymphony A1”, offering new capabilities to researchers in small as well as large labs by performing exploratory experiments without tying up freestanding cell analyzers

Emerging Opportunities in the Life Science Tools and Services Market

• Greater Acceptance of Genomics
• NCCN guideline adoption: The National Comprehensive Cancer Network (NCCN) has recommended the adoption of genetic panel testing in ovarian and breast cancer testing, to help find mutations
• Shift towards consumerism: Shift towards a more consumer-oriented model is expected to drive the demand for genomic technologies to understand future health outcomes

• Bioproduction, a fast-growing area
• Growth within biosimilars: The biosimilars market exhibits a high CAGR due to low cost and increased demand which further drive the expansion of the bioproduction industry
• Access to healthcare in emerging markets: Large molecule drugs have seen high growth in emerging markets and is expected that pharmerging economies will drive the medicine volume usage in next five years

• Focus on Food Testing & Environmental Health
• Food testing: Increased global food safety regulations, corporate brand management, and increasing emphasis on efficient livestock and agricultural production have contributed to the growth of the life science tools and services market for food testing
• Environmental health: Improving the quality of the soil, air, and water as well as cleaning up pollutants falls under the environmental health agenda. Governments now seem to be more committed to these programs for better quality

North America is expected to hold a major share in the Global Life Science Tools and Services Market

From a geographical perspective, North America holds a major market share of the life science tools and services market. This can be mainly attributed to the growing number of genomic procedures, rapid growth in biologics coupled with opportunities in biosimilars, and increased access to advanced technologies. However, the Asia Pacific is expected to ascend at the fastest CAGR over the forecast period on account of the large customer base and growing health concerns in key markets such as Japan, China & India and the increasing focus of major players on pharmaceutical R&D outsourcing.

Get PDF Report for Competitive Analysis: 
https://meditechinsights.com/life-science-tools-and-services-market/request-sample/

Competitive Landscape Analysis

The global life science tools and services market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Becton; Dickinson and Company; Bio-Rad Laboratories, Inc.; Merck KGaA; Danaher Corporation; Illumina, Inc.; Thermo Fisher Scientific, Inc; QIAGEN N.V.; Shimadzu Corporation; Hitachi Ltd.; Bruker Corporation; Oxford Instruments plc; and Zeiss International among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

Players operating in this market are adopting both organic and inorganic growth strategies such as collaborations, and acquisitions to garner market share. For instance,

• In September 2024, Agilent Technologies Inc. finalized its acquisition of BIOVECTRA, specializing in biologics, highly potent active pharmaceutical ingredients, and molecules for targeted therapeutics, expanding its specialized CDMO offerings for pharmaceutical customers
• In November 2023, Thermo Fisher Scientific and Flagship Pioneering announced a strategic partnership aimed at developing and scaling multiproduct platforms, focusing on establishing new companies that will leverage innovative tools and capabilities to expedite therapy development
• In January 2023, Agilent Technologies Inc. announced its acquisition of Avida Biomed, a life sciences company specializing in high-performance NGS target enrichment workflows that enable simultaneous genomic and epigenomic profiling for cancer research, aimed at advancing precision medicine

The market continues to evolve with ongoing research, technological innovations, an increasing focus on precision medicine, increasing government funding and aggressive organic and inorganic growth strategies followed by the players.

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com